Impress employers and recruiters.
Choose from hundreds of resume examples.
Impress employers and recruiters.
Choose from hundreds of resume examples.
Target Resume Now
About the Role
This is a founding leadership role focused on reforming federal policy and law governing clinical trials to make them faster, cheaper, and simpler. The work involves shaping legislative and regulatory reform agendas and building a coalition of stakeholders to support clinical trial abundance.
Responsibilities
- Serve as the initiative's lead voice with legislators, congressional staff, agency officials, health-system and industry leaders, building credibility and trust.
- Shape a substantive agenda to reform policy and law around the cost, speed, and complexity of trials, driving it into the PDUFA 2027 reauthorization and implementation.
- Design and build a coalition of companies, investors, research and patient organizations, and allied policymakers.
- Translate the scientific and regulatory case for reform into arguments that move different audiences.
- Set the initiative's strategy for the years beyond 2027, focusing on field-building.
Requirements
- Deep credibility in biotech, life sciences, or FDA/clinical-trial policy.
- A track record of being taken seriously by senior, varied stakeholders including Hill offices, agencies, industry executives, investors, and researchers.
- Evidence of ability to build something durable, not only win a near-term legislative fight.
- Fluent in making the case for reform that expands what's possible by cutting friction, cost, and time between science and patients.
Skills
- Policy reform
- Law reform
- Legislative strategy
- Regulatory reform
- Coalition building
- Stakeholder engagement
- Communication
- Strategic planning
Location
- Remote
Work Type
- Work From Home
Experience Level
- Founding leadership
Salary/Compensations
- 200000-250000 USD/year
Benefits
- Private Health Insurance
- Paid Time Off
- Training & Development
About the Company
- The Clinical Trial Abundance Initiative is a new, founder-led effort backed by a coalition of leading science philanthropies.
- The initiative aims to reform federal policy and law governing clinical trials to make them dramatically faster, cheaper, and simpler to conduct.
- The 2027 reauthorization of the Prescription Drug User Fee Act (PDUFA) is a key window for reform.